NASDAQ:VIRX

Viracta Therapeutics News Headlines

Add
Compare
Today's Range N/A
50-Day Range
$7.55
$11.02
52-Week Range N/A
Volume244,980 shs
Average Volume750,337 shs
Market Capitalization$54.38 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Viracta Therapeutics (NASDAQ VIRX) News Headlines Today

SourceHeadline
Viracta Therapeutics (NASDAQ:VIRX) Earns Outperform Rating from Analysts at SVB LeerinkViracta Therapeutics (NASDAQ:VIRX) Earns Outperform Rating from Analysts at SVB Leerink
americanbankingnews.com - May 3 at 9:38 AM
Viracta Therapeutics (NASDAQ:VIRX) Now Covered by HC WainwrightViracta Therapeutics (NASDAQ:VIRX) Now Covered by HC Wainwright
americanbankingnews.com - May 3 at 8:10 AM
Analysts Bet on These 2 Biotech Stocks; See Over 50% Upside PotentialAnalysts Bet on These 2 Biotech Stocks; See Over 50% Upside Potential
finance.yahoo.com - April 29 at 8:25 AM
Equities Analysts Set Expectations for Viracta Therapeutics, Inc.s Q1 2021 Earnings (NASDAQ:VIRX)Equities Analysts Set Expectations for Viracta Therapeutics, Inc.'s Q1 2021 Earnings (NASDAQ:VIRX)
americanbankingnews.com - April 29 at 7:12 AM
Viracta Therapeutics (NASDAQ:VIRX) Coverage Initiated by Analysts at SVB LeerinkViracta Therapeutics (NASDAQ:VIRX) Coverage Initiated by Analysts at SVB Leerink
americanbankingnews.com - April 26 at 1:48 PM
Zacks: Analysts Anticipate Viracta Therapeutics, Inc. (NASDAQ:VIRX) Will Announce Earnings of -$0.13 Per ShareZacks: Analysts Anticipate Viracta Therapeutics, Inc. (NASDAQ:VIRX) Will Announce Earnings of -$0.13 Per Share
americanbankingnews.com - April 26 at 10:32 AM
Viracta Therapeutics to Present at the 20th Annual Needham Virtual Healthcare ConferenceViracta Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 8 at 8:54 AM
Viracta Therapeutics, Inc. Rings the Closing BellViracta Therapeutics, Inc. Rings the Closing Bell
nasdaq.com - March 13 at 7:13 AM
Viracta Therapeutics, Inc. Rings the Nasdaq Stock Market Closing BellViracta Therapeutics, Inc. Rings the Nasdaq Stock Market Closing Bell
nasdaq.com - March 12 at 9:12 PM
Viracta Therapeutics to Present at the Oppenheimer 31st Annual Healthcare ConferenceViracta Therapeutics to Present at the Oppenheimer 31st Annual Healthcare Conference
finance.yahoo.com - March 11 at 9:33 AM
Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management TeamViracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team
finance.yahoo.com - March 4 at 8:47 AM
Viracta Therapeutics to Participate at H.C. Wainwright Global Life Sciences ConferenceViracta Therapeutics to Participate at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 3 at 12:39 PM
This page was last updated on 5/6/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.